Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,156.00
Bid: 12,124.00
Ask: 12,128.00
Change: -14.00 (-0.12%)
Spread: 4.00 (0.033%)
Open: 12,114.00
High: 12,258.00
Low: 12,114.00
Prev. Close: 12,170.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Almost half of Irish adults now fully vaccinated against Covid-19

Sat, 03rd Jul 2021 14:01

(Alliance News) - Almost half of Irish adults are now fully vaccinated against Covid-19, HSE Chief Executive Paul Reid has said.

New figures released on Saturday show that 48% of adults, 1.8 million people, have now received two doses of the vaccine, while another 68%, 2.56 million, have had their first dose.

It comes after the government announced a number of new measures aimed at boosting the vaccination rollout, in a race against the more transmissible Delta variant.

Reid said Ireland must plan for the Delta variant with "concern", but with "a level of confidence also".

He tweeted: "Almost 4.3M vaccines administered. Over 2.56M adults partially vaccinated (68%) & over 1.8M (48%) fully vaccinated.

"Over 55,000 administered on each of the last 4 days, & over 272,000 so far this week."

Efforts to ramp up the vaccination programme are ongoing, amid the threat posed by the Delta variant and a recommendation from public health experts that indoor hospitality not return until a system can be set up allowing only vaccinated customers to enter.

As part of those efforts, Ireland on Friday agreed a deal in principle to purchase one million unwanted vaccines from Romania.

Taoiseach Micheal Martin spoke to Romanian President Klaus Iohannis, when a deal was agreed, however it is yet to be finalised.

It followed an earlier announcement that the rollout will be accelerated for people aged 18 to 34.

It follows updated advice from the National Immunisation Advisory Committee that the AstraZeneca and Johnson & Johnson vaccines can be given to people under 40.

People aged 18 to 34 can now "opt in" for one of those jabs, or choose to wait for an mRNA vaccine such as Pfizer or Moderna.

The opt-in system will run in parallel with the online registration portal, which will open for the 30 to 34-year-old age cohort next Friday.

Health Minister Stephen Donnelly told the Dail that "a significant acceleration of the vaccine programme" will begin from Monday.

He said: "In short, the changes that we're implementing from Monday will mean that the 18 to 34-year-old age group will have the option of being vaccinated one to two months early."

He added: "To be able to pull forward a huge number of people from September to August, and some from August into July, is incredibly valuable.

"It's really going to help us protecting each other and protect our population from the Delta surge that we know is coming."

It comes after Chief Medical Officer Tony Holohan warned a fourth wave of Covid-19, driven by the Delta variant, cannot be stopped, and will lead to higher levels of hospital admissions and death.

The accelerated vaccine rollout will fail to halt an exponential rise in cases in July and August, he said, but should help bring the situation under control in September.

By James Ward, PA

source: PA

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more
25 Apr 2024 09:18

TOP NEWS: AstraZeneca upbeat as cancer drugs underpin sales growth

(Alliance News) - AstraZeneca PLC on Thursday hailed the potential of its drugs pipeline as it delivered impressive growth in sales and profit in the first quarter.

Read more
25 Apr 2024 09:12

LONDON MARKET OPEN: Anglo American jumps on takeover bid from BHP

(Alliance News) - Stock prices in London opened mixed on Thursday, as investors cautiously eye data on the health of the US economy.

Read more
25 Apr 2024 08:38

AstraZeneca blows past analysts' estimates for Q1

(Sharecast News) - AstraZeneca posted better-than-expected revenues and profit for the first quarter of 2024 with both the company and analysts highlighting its drug pipeline.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.